T2-low: What do we know? - Past, present, and future of biologic therapies in non-eosinophilic asthma. Niessen NM, Fricker M, McDonald VM, Gibson PG, et al. Ann Allergy Asthma Immunol 2022 Apr 26. pii: S1081-1206(22)00342.

Read + Share

Amedeo Smart

Independent Medical Education

Niessen NM, Fricker M, McDonald VM, Gibson PG, et al. T2-low: What do we know? - Past, present, and future of biologic therapies in non-eosinophilic asthma. Ann Allergy Asthma Immunol 2022 Apr 26. pii: S1081-1206(22)00342.
PMID: 35487388